Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA AUROBINDO PHARMA CIPLA/
AUROBINDO PHARMA
 
P/E (TTM) x 25.9 13.7 189.1% View Chart
P/BV x 3.3 1.1 299.3% View Chart
Dividend Yield % 0.6 1.9 30.2%  

Financials

 CIPLA   AUROBINDO PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-22
AUROBINDO PHARMA
Mar-22
CIPLA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0831,064 101.8%   
Low Rs806584 138.0%   
Sales per share (Unadj.) Rs269.7400.3 67.4%  
Earnings per share (Unadj.) Rs31.745.7 69.4%  
Cash flow per share (Unadj.) Rs44.864.9 68.9%  
Dividends per share (Unadj.) Rs5.009.00 55.6%  
Avg Dividend yield %0.51.1 48.5%  
Book value per share (Unadj.) Rs257.8419.4 61.5%  
Shares outstanding (eoy) m806.81585.94 137.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.52.1 170.1%   
Avg P/E ratio x29.818.0 165.2%  
P/CF ratio (eoy) x21.112.7 166.3%  
Price / Book Value ratio x3.72.0 186.5%  
Dividend payout %15.819.7 80.1%   
Avg Mkt Cap Rs m762,177482,799 157.9%   
No. of employees `000NANA-   
Total wages/salary Rs m35,29934,509 102.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m217,633234,555 92.8%  
Other income Rs m3,2173,226 99.7%   
Total revenues Rs m220,851237,781 92.9%   
Gross profit Rs m43,29842,566 101.7%  
Depreciation Rs m10,52011,265 93.4%   
Interest Rs m1,064486 218.6%   
Profit before tax Rs m34,93334,040 102.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3387,256 128.7%   
Profit after tax Rs m25,59526,784 95.6%  
Gross profit margin %19.918.1 109.6%  
Effective tax rate %26.721.3 125.4%   
Net profit margin %11.811.4 103.0%  
BALANCE SHEET DATA
Current assets Rs m147,108181,227 81.2%   
Current liabilities Rs m49,12981,560 60.2%   
Net working cap to sales %45.042.5 106.0%  
Current ratio x3.02.2 134.8%  
Inventory Days Days6225 245.7%  
Debtors Days Days662 9.2%  
Net fixed assets Rs m119,248155,104 76.9%   
Share capital Rs m1,614586 275.4%   
"Free" reserves Rs m206,364245,174 84.2%   
Net worth Rs m207,977245,760 84.6%   
Long term debt Rs m4,1622,492 167.0%   
Total assets Rs m266,523336,331 79.2%  
Interest coverage x33.871.0 47.7%   
Debt to equity ratio x00 197.4%  
Sales to assets ratio x0.80.7 117.1%   
Return on assets %10.08.1 123.4%  
Return on equity %12.310.9 112.9%  
Return on capital %17.013.9 122.0%  
Exports to sales %26.231.1 84.5%   
Imports to sales %8.211.9 68.6%   
Exports (fob) Rs m57,09472,862 78.4%   
Imports (cif) Rs m17,80327,965 63.7%   
Fx inflow Rs m60,18077,245 77.9%   
Fx outflow Rs m17,80331,524 56.5%   
Net fx Rs m42,37645,721 92.7%   
CASH FLOW
From Operations Rs m33,25950,165 66.3%  
From Investments Rs m-18,719-32,116 58.3%  
From Financial Activity Rs m-15,998-29,693 53.9%  
Net Cashflow Rs m-1,323-11,674 11.3%  

Share Holding

Indian Promoters % 13.5 48.8 27.6%  
Foreign collaborators % 20.1 3.1 655.7%  
Indian inst/Mut Fund % 49.5 37.2 132.9%  
FIIs % 28.4 22.3 127.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 48.2 137.8%  
Shareholders   404,182 369,828 109.3%  
Pledged promoter(s) holding % 0.0 17.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    LAURUS LABS     


More on Cipla vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Aurobindo Pharma Share Price Performance

Period Cipla Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -0.52% -1.06% -0.31%
1-Month -10.69% 1.99% -2.88%
1-Year -17.83% -30.92% -11.65%
3-Year CAGR 31.71% 16.81% 24.90%
5-Year CAGR 9.44% -3.57% 9.89%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.6% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of 15.8%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of Cipla, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms 446 Points, Nifty Above 17,100 | Reliance & Titan Surge 3% | Power Grid & HUL Down 2% Sensex Today Zooms 446 Points, Nifty Above 17,100 | Reliance & Titan Surge 3% | Power Grid & HUL Down 2%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum throughout the trading session and ended on a firm footing.